Michelle Dasaro

, United States


Presentations

Study Protocol for a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Impact of Apremilast on Quality of Life, Efficacy, and Safety in Patients With Specific Manifestations of Psoriasis and Impaired Quality of Life (EMBRACE) 09 October 2019 00:00 - 00:00
Real-World Efficacy of Apremilast in Patients With Psoriasis With and Without Comorbid Psoriatic Arthritis: Findings From the Corrona Psoriasis Registry 09 October 2019 00:00 - 00:00
Characteristics of Psoriasis Patients and Use of Apremilast Classified by Psoriasis Severity and Disease Burden: Results From the Corrona Psoriasis Registry 09 October 2019 00:00 - 00:00
Apremilast Real-World Treatment Outcomes in Psoriasis Patients With Comorbid Psoriatic Arthritis: An Analysis of the APPRECIATE Study 09 October 2019 00:00 - 00:00
Efficacy of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Subgroup Analysis of Results From a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study 09 October 2019 00:00 - 00:00
Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: 32-Week Results From the Phase 3, STYLE Study 09 October 2019 00:00 - 00:00